PDS Biotechnology Q2 EPS $(0.18) Misses $(0.13) Estimate

PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.13) by 38.46 percent. This is a 14.29 percent increase over losses of $(0.21) per share from the same period last year.